NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.34
+0.00 (+0.74%)
As of May 16, 2:31 AM ET ·
Financial Highlights (FY 2026)
Revenue
375.9K
Net Income
-10,248,396
Gross Margin
79.7%
Profit Margin
-2,725.7%
Rev Growth
-38.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 79.7% 79.7% 58.5% 58.5%
Operating Margin -2,781.7% -2,503.5% 15.6% 16.3%
Profit Margin -2,725.7% -2,589.5% 10.4% 11.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 375.9K 615.1K 3.31M 3.62M
Gross Profit 299.5K 490.0K 1.94M 2.12M
Operating Income -10,457,316 -15,398,534 514.6K 589.5K
Net Income -10,248,396 -15,090,897 342.9K 405.7K
Gross Margin 79.7% 79.7% 58.5% 58.5%
Operating Margin -2,781.7% -2,503.5% 15.6% 16.3%
Profit Margin -2,725.7% -2,589.5% 10.4% 11.2%
Rev Growth -38.9% -38.9% +22.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.24M 3.21M
Total Equity 3.39M 3.33M
D/E Ratio 0.95 0.96
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,415,934 -16,189,687 846.1K 883.2K
Free Cash Flow 192.0K 243.4K